GAITHERSBURG, MD, March 14, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…
New investment will enhance immunochemistry and chromatography services, helping pharma and biotech customers accelerate drug development March 14, 2022…